• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Rep . Differential immunity induced by Omicron sublineages in naïve and vaccine breakthrough infections

tetano

Editor, Senior Moderator
Sci Rep


. 2025 Jul 3;15(1):23718.
doi: 10.1038/s41598-025-07702-2. Differential immunity induced by Omicron sublineages in naïve and vaccine breakthrough infections

Noah Brazer[SUP] #[/SUP][SUP] 1 [/SUP], Mary Kate Morris[SUP] #[/SUP][SUP] 2 [/SUP], Venice Servellita[SUP] 1 [/SUP], Miriam Oseguera[SUP] 1 [/SUP], Nanami Sumimoto[SUP] 1 [/SUP], Prachi Saldhi[SUP] 1 [/SUP], Abiodun Foresythe[SUP] 1 [/SUP], Jenny Nguyen[SUP] 1 [/SUP], Debra A Wadford[SUP] 2 [/SUP], Carl Hanson[SUP] 3 [/SUP], Charles Y Chiu[SUP] 4 5 6 7 [/SUP]



Affiliations
Abstract

The emergence of the Omicron variant in late 2021 gave rise to multiple descendent lineages, or sublineages, with progressively increased capacity for antibody evasion. Here we used live virus neutralization assays to quantify and compare homologous ("self") and cross-neutralizing antibody titers in 170 COVID-19 patients infected with either the Delta variant or an Omicron sublineage (BA.1, BA.2, BA.4/BA.5, BQ.1.1, and XBB.1.5) and 25 uninfected controls who had received the BA.5 bivalent booster vaccine. In control subjects, neutralizing antibody titers against BA.5 and earlier sublineages were significantly higher than against the later BQ.1.1 or XBB.1.5 sublineages, and differences in antibody titers between immunocompetent and immunocompromised individuals were not significant. In patients infected with an Omicron sublineage, induced cross-neutralizing antibody responses were weaker and less durable against later compared to earlier sublineages. Self-neutralizing antibody titers against BQ.1.1 or XBB.1.5 in patients infected with these sublineages were also lower than cross-neutralizing titers against earlier sublineages. Our results suggest that immunological imprinting resulting from prior exposure to SARS-CoV-2 ("original antigenic sin"), whether via natural infection or vaccination, may have impaired neutralizing antibody responses to the later Omicron sublineages. The poorer elicited immunogenicity and increased capacity for antibody evasion of these sublineages explain in part their persistence and ongoing global circulation.

Keywords: BA.1; BA.2; BA.4; BA.5; BF; BQ.1; Breakthrough infection; COVID-19; Delta; Neutralizing antibodies; Omicron; SARS-CoV-2 variants; Vaccine boosting; XBB.

 
Back
Top Bottom